CAMBRIDGE, Mass. & BASEL, Switzerland & BEIJING–(BUSINESS WIRE)–BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, today announced that the Company will participate in two upcoming investor conferences:
A live webcast can be accessed from the investors section of BeiGene�s websites at https://ir.beigene.com, https://hkexir.beigene.com and https://sseir.beigene.com. An archived replay will be available for 90 days following the event.
About BeiGene
BeiGene is a global biotechnology company that is developing and commercializing innovative and affordable oncology medicines to improve treatment outcomes and access for far more patients worldwide. With a broad portfolio, we are expediting development of our diverse pipeline of novel therapeutics through our internal capabilities and collaborations. We are committed to radically improving access to medicines for far more patients who need them. Our growing global team of more than 9,000 colleagues spans five continents, with administrative offices in Beijing, China; Cambridge, U.S.; and Basel, Switzerland. To learn more about BeiGene, please visit www.beigene.com and follow us on Twitter at @BeiGeneGlobal.
Contacts
Investor
Kevin Mannix
+1-857-302-5189
ir@beigene.com
Media
Kyle Blankenship
+1 667-351-5176
media@beigene.com
Laying a Solid Foundation for the Development of ESG Investment and Green Innovation Calling for…
The Philippine meat industry will be shown the quality and guarantees of European beef MANILA,…
"It’s Time for European Beef" is a campaign led by Provacuno and co-funded by the…
MACAU SAR - Media OutReach Newswire - 27 March 2025 - The world-class luxurious Galaxy…
In an effort to achieve a target of 80% of patients controlling the three highs…
Strengthen the “Single Brand, Multi-Categories, Diversified Channels” Strategy | Solidify Brand and Product Competitiveness, Ensure…